Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymph Nodes | 8 | 2024 | 548 | 4.500 |
Why?
|
| Lab-On-A-Chip Devices | 6 | 2023 | 23 | 2.630 |
Why?
|
| Microfluidics | 9 | 2022 | 52 | 2.270 |
Why?
|
| B-Lymphocytes | 5 | 2024 | 739 | 1.390 |
Why?
|
| Tissue Survival | 3 | 2020 | 13 | 1.060 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 3218 | 1.040 |
Why?
|
| Printing, Three-Dimensional | 2 | 2023 | 40 | 1.000 |
Why?
|
| Vaccination | 2 | 2024 | 274 | 0.970 |
Why?
|
| Antibodies | 2 | 2019 | 353 | 0.970 |
Why?
|
| Chemokine CXCL9 | 1 | 2024 | 8 | 0.970 |
Why?
|
| Poly I-C | 1 | 2024 | 18 | 0.960 |
Why?
|
| Interferon-gamma | 2 | 2024 | 451 | 0.960 |
Why?
|
| Lymphocytes | 2 | 2023 | 471 | 0.910 |
Why?
|
| Xylenes | 1 | 2023 | 5 | 0.900 |
Why?
|
| Interferon Type I | 1 | 2024 | 185 | 0.880 |
Why?
|
| Oxygen Consumption | 1 | 2024 | 244 | 0.870 |
Why?
|
| Mice | 15 | 2024 | 11761 | 0.860 |
Why?
|
| Tissue Engineering | 2 | 2022 | 185 | 0.830 |
Why?
|
| Polymers | 1 | 2023 | 194 | 0.810 |
Why?
|
| CD3 Complex | 2 | 2019 | 134 | 0.790 |
Why?
|
| Animals | 20 | 2024 | 27369 | 0.780 |
Why?
|
| Digitonin | 1 | 2020 | 10 | 0.750 |
Why?
|
| Detergents | 1 | 2020 | 34 | 0.750 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2020 | 7 | 0.750 |
Why?
|
| Boron Compounds | 1 | 2020 | 20 | 0.710 |
Why?
|
| Polyesters | 1 | 2020 | 41 | 0.700 |
Why?
|
| Microfluidic Analytical Techniques | 3 | 2017 | 45 | 0.700 |
Why?
|
| In Vitro Techniques | 2 | 2021 | 996 | 0.660 |
Why?
|
| Th1 Cells | 2 | 2024 | 166 | 0.660 |
Why?
|
| Pepsin A | 1 | 2019 | 5 | 0.660 |
Why?
|
| Spleen | 1 | 2020 | 433 | 0.650 |
Why?
|
| Leukocyte Common Antigens | 1 | 2018 | 48 | 0.640 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 244 | 0.630 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2018 | 97 | 0.630 |
Why?
|
| Frozen Sections | 1 | 2018 | 49 | 0.630 |
Why?
|
| Lectins, C-Type | 1 | 2018 | 86 | 0.620 |
Why?
|
| Cytokines | 3 | 2020 | 803 | 0.610 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 323 | 0.610 |
Why?
|
| Glucose | 1 | 2020 | 630 | 0.590 |
Why?
|
| Nonlinear Dynamics | 2 | 2017 | 73 | 0.590 |
Why?
|
| Optical Imaging | 1 | 2017 | 50 | 0.580 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 82 | 0.560 |
Why?
|
| Antigens, CD | 1 | 2018 | 466 | 0.560 |
Why?
|
| Osteoporosis | 1 | 2017 | 122 | 0.530 |
Why?
|
| Diffusion | 4 | 2017 | 93 | 0.520 |
Why?
|
| Signal Transduction | 2 | 2024 | 3384 | 0.510 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 273 | 0.490 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 308 | 0.480 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 757 | 0.470 |
Why?
|
| Blood Coagulation | 3 | 2009 | 92 | 0.460 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2014 | 88 | 0.450 |
Why?
|
| Liver | 1 | 2018 | 1208 | 0.440 |
Why?
|
| Th2 Cells | 1 | 2014 | 147 | 0.440 |
Why?
|
| Nanofibers | 3 | 2017 | 32 | 0.380 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 445 | 0.380 |
Why?
|
| Adaptive Immunity | 2 | 2023 | 167 | 0.370 |
Why?
|
| Antigens | 2 | 2023 | 229 | 0.370 |
Why?
|
| Immune System | 2 | 2022 | 97 | 0.360 |
Why?
|
| Equipment Design | 3 | 2022 | 417 | 0.350 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1194 | 0.350 |
Why?
|
| Thrombin | 2 | 2009 | 61 | 0.330 |
Why?
|
| Models, Theoretical | 1 | 2012 | 491 | 0.320 |
Why?
|
| Adjuvants, Immunologic | 2 | 2024 | 168 | 0.320 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 35 | 0.310 |
Why?
|
| Biological Transport | 2 | 2020 | 401 | 0.310 |
Why?
|
| Peptides | 3 | 2017 | 648 | 0.300 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 428 | 0.280 |
Why?
|
| T-Lymphocytes | 3 | 2024 | 1224 | 0.260 |
Why?
|
| Surface Properties | 2 | 2018 | 131 | 0.250 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 2362 | 0.240 |
Why?
|
| Rotation | 1 | 2022 | 91 | 0.200 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2022 | 78 | 0.200 |
Why?
|
| Models, Biological | 4 | 2022 | 1765 | 0.190 |
Why?
|
| Humans | 11 | 2023 | 89349 | 0.190 |
Why?
|
| Tissue Array Analysis | 1 | 2021 | 127 | 0.190 |
Why?
|
| Biophysics | 1 | 2021 | 153 | 0.190 |
Why?
|
| Stress, Mechanical | 1 | 2022 | 253 | 0.190 |
Why?
|
| Ninhydrin | 1 | 2020 | 1 | 0.180 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2020 | 12 | 0.180 |
Why?
|
| Gelatin | 1 | 2020 | 25 | 0.180 |
Why?
|
| Cell Tracking | 1 | 2020 | 14 | 0.180 |
Why?
|
| Thymus Gland | 1 | 2021 | 197 | 0.180 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2020 | 85 | 0.180 |
Why?
|
| Computer Simulation | 2 | 2023 | 1097 | 0.170 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 277 | 0.170 |
Why?
|
| Hydrogels | 1 | 2020 | 86 | 0.170 |
Why?
|
| Oxygen | 1 | 2024 | 743 | 0.160 |
Why?
|
| Antibody Affinity | 1 | 2019 | 38 | 0.160 |
Why?
|
| Coculture Techniques | 1 | 2019 | 174 | 0.160 |
Why?
|
| Nanoparticles | 1 | 2020 | 164 | 0.160 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 81 | 0.160 |
Why?
|
| Female | 6 | 2024 | 46200 | 0.160 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2019 | 83 | 0.150 |
Why?
|
| Cell Communication | 1 | 2019 | 199 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2758 | 0.150 |
Why?
|
| Macrophages | 1 | 2021 | 571 | 0.150 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 501 | 0.150 |
Why?
|
| Vaccines, Subunit | 2 | 2017 | 55 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2021 | 430 | 0.150 |
Why?
|
| Antibody Formation | 2 | 2017 | 171 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1088 | 0.140 |
Why?
|
| Tuberculosis Vaccines | 1 | 2015 | 17 | 0.130 |
Why?
|
| Perfusion | 1 | 2016 | 236 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 540 | 0.130 |
Why?
|
| Cell Movement | 1 | 2019 | 784 | 0.130 |
Why?
|
| Neoplasms | 2 | 2022 | 3041 | 0.120 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 136 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2884 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 699 | 0.110 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2015 | 195 | 0.110 |
Why?
|
| Vaccines | 1 | 2014 | 83 | 0.110 |
Why?
|
| Viscosity | 1 | 2012 | 46 | 0.100 |
Why?
|
| Biomarkers | 1 | 2018 | 1767 | 0.100 |
Why?
|
| Nuclear Energy | 1 | 2011 | 1 | 0.100 |
Why?
|
| Radiochemistry | 1 | 2011 | 5 | 0.100 |
Why?
|
| Chemical Fractionation | 1 | 2011 | 7 | 0.100 |
Why?
|
| Lanthanoid Series Elements | 1 | 2011 | 11 | 0.100 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 94 | 0.100 |
Why?
|
| Solvents | 1 | 2011 | 96 | 0.100 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 276 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 2415 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 892 | 0.080 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2008 | 42 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 922 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2008 | 184 | 0.070 |
Why?
|
| Valinomycin | 1 | 2005 | 8 | 0.060 |
Why?
|
| Epitopes | 2 | 2017 | 255 | 0.060 |
Why?
|
| Lipid Bilayers | 1 | 2005 | 136 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 2015 | 0.060 |
Why?
|
| Drug Liberation | 1 | 2022 | 16 | 0.050 |
Why?
|
| Kinetics | 3 | 2011 | 1528 | 0.050 |
Why?
|
| Chemical Precipitation | 1 | 2020 | 18 | 0.050 |
Why?
|
| Inflammation | 2 | 2017 | 972 | 0.040 |
Why?
|
| Bacillus cereus | 2 | 2009 | 10 | 0.040 |
Why?
|
| Sex Factors | 1 | 2022 | 1066 | 0.040 |
Why?
|
| Immunotherapy, Active | 1 | 2017 | 15 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 2017 | 42 | 0.040 |
Why?
|
| Particle Size | 1 | 2017 | 124 | 0.040 |
Why?
|
| Male | 1 | 2020 | 42410 | 0.040 |
Why?
|
| Listeriosis | 1 | 2017 | 86 | 0.040 |
Why?
|
| Age Factors | 1 | 2022 | 1870 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2017 | 107 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 293 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2013 | 5 | 0.030 |
Why?
|
| B7-2 Antigen | 1 | 2013 | 40 | 0.030 |
Why?
|
| B7-1 Antigen | 1 | 2013 | 76 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 91 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2013 | 135 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 198 | 0.020 |
Why?
|
| Actinoid Series Elements | 1 | 2011 | 1 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2011 | 34 | 0.020 |
Why?
|
| Phosphorus | 1 | 2011 | 117 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1412 | 0.020 |
Why?
|
| Thromboplastin | 1 | 2009 | 7 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2009 | 21 | 0.020 |
Why?
|
| Water | 1 | 2011 | 283 | 0.020 |
Why?
|
| Plasma | 1 | 2009 | 51 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2013 | 449 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 103 | 0.020 |
Why?
|
| Factor X | 1 | 2008 | 3 | 0.020 |
Why?
|
| Prothrombin | 1 | 2008 | 17 | 0.020 |
Why?
|
| Metalloproteases | 1 | 2008 | 10 | 0.020 |
Why?
|
| Quorum Sensing | 1 | 2008 | 28 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 421 | 0.020 |
Why?
|
| Bacillus anthracis | 1 | 2008 | 73 | 0.020 |
Why?
|
| Environment | 1 | 2009 | 223 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2005 | 9 | 0.020 |
Why?
|
| Ion Transport | 1 | 2005 | 81 | 0.020 |
Why?
|
| Liposomes | 1 | 2005 | 93 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 1877 | 0.010 |
Why?
|